Filing Details
- Accession Number:
- 0001213900-21-027682
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-18 17:00:58
- Reporting Period:
- 2021-05-14
- Accepted Time:
- 2021-05-18 17:00:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 812796 | Soligenix Inc. | SNGX | Pharmaceutical Preparations (2834) | 411505029 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1433982 | B Jerome Zeldis | 29 Emmons Drive, Suite B-10 Princeton NJ 08540 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-14 | 3,000 | $0.89 | 25,917 | No | 4 | P | Direct | |
| Common Stock | Disposition | 2021-05-14 | 3,000 | $0.90 | 22,917 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | S | Direct |
Footnotes
- The Reporting Person's sale of 3,000 shares of the Issuer's common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, with the purchase of 3,000 shares of the Issuer's common stock reported herein. The Reporting Person has voluntarily agreed to disgorge to the Issuer the full amount of the resulting statutory "profit" calculated pursuant to Section 16(b) of the Securities Exchange Act of 1934, as amended.
Billionaire Hedge Funds
